GDF2026 - Q&A Discussion Panel Two
FDA IID Q&A Panel · July 30, 2026
A public FDA panel session on the Inactive Ingredient Database (IID) and related regulatory questions, including how to handle excipients not listed in the IID, calculation of maximum daily exposure (MDE) and maximum daily dose (MDD), diastereomer testing for oligonucleotides, and reporting thresholds for unspecified impurities.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.